Last reviewed · How we verify
NCT02886533: SACHA
Major Bleeding Risk Associated With Antithrombotics
trial testing Antithrombotic in Major Haemorrhage in 6,484 participants. Completed in 31 December 2015.
31 December 2015
Quick facts
| Lead sponsor | Rennes University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 6,484 |
| Start date | 1 January 2013 |
| Primary completion | 31 December 2015 |
| Estimated completion | 31 December 2015 |
| Sites | 12 locations across France |
Drugs / interventions tested
- Antithrombotic
Conditions studied
- Major Haemorrhage — all drugs for Major Haemorrhage →
Sponsor
Rennes University Hospital
Who can join
18 and older, any sex, with Major Haemorrhage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective, multicenter, observational study with a three-year inclusion period (from January 1, 2012 to December 31, 2015) and a 6-month follow-up
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study.
Bouget J, Balusson F, Viglino D, Roy PM, et al · · 2020 · cited 22× · PMID 32764775 · DOI 10.1371/journal.pone.0237022 -
Major bleeding risk associated with oral anticoagulant in real clinical practice. A multicentre 3-year period population-based prospective cohort study.
Bouget J, Balusson F, Maignan M, Pavageau L, et al · · 2020 · cited 14× · PMID 32415705 · DOI 10.1111/bcp.14362 -
Clinical use of low-dose parenteral anticoagulation, incidence of major bleeding and mortality: a multi-centre cohort study using the French national health data system.
Bouget J, Balusson F, Kerbrat S, Roy PM, et al · · 2022 · cited 2× · PMID 35385975 · DOI 10.1007/s00228-022-03318-x -
Management of epistaxis associated with oral antithrombotic drugs in emergency department and impact on prescription thereafter.
Bouget J, Balusson F, Roy PM, Viglino D, et al · · 2023 · PMID 36789614 · DOI 10.1111/coa.14040
Verify or expand the search:
- PubMed search for NCT02886533
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Rennes University Hospital trials
Trials by the same sponsor.
- NCT07527949 — PASTRAMI : Patient-specific Statistics for Microstructure-augmented Connectomics · NA · not yet recruiting
- NCT07449832 — Sperm Epigenome in Hodgkin Lymphoma · NA · not yet recruiting
- NCT06950398 — Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers · Phase 2 · not yet recruiting
- NCT07188753 — Randomized Controlled Trial Testing the Efficacy of Transcranial Magnetic Stimulation by Accelerated & High-dose Theta-b · NA · not yet recruiting
- NCT06898099 — Evaluation of the Efficacy of E2R Hypnotherapy in the Management of Chronic Insomnia in Primary Care (HypERR) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02886533 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rennes University Hospital
- Last refreshed: 18 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02886533.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing